Cancer Hormone Therapy Drugs Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 157 Category: Pharma & Healthcare Report Code : HC0114588
Cancer Hormone Therapy Drugs Market By Type (Tamoxifen, Aromatase Inhibitors, Antiandrogens, Androgen Synthesis Inhibitors, Other) and Application (Breast Cancer, Prostate Cancer, Other type of Cancers)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Cancer Hormone Therapy Drugs Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Cancer Hormone Therapy is often used after surgery (as adjuvant therapy) to help reduce the risk of the cancer coming back.Hormone therapy can also be used to treat cancer that has come back after treatment or that has spread to other parts of the body.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Cancer Hormone Therapy Drugs Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Roche
- Amgen
- Pfizer
- Teva
- Takeda
- Samyang Biopharmaceuticals
- Tolmar
- AstraZeneca
- Novartis
- Aspen
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Cancer Hormone Therapy Drugs Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Tamoxifen
o Aromatase Inhibitors
o Antiandrogens
o Androgen Synthesis Inhibitors
o Other
· Cancer Hormone Therapy Drugs Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Breast Cancer
o Prostate Cancer
o Other type of Cancers
· Cancer Hormone Therapy Drugs Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Roche
o Amgen
o Pfizer
o Teva
o Takeda
o Samyang Biopharmaceuticals
o Tolmar
o AstraZeneca
o Novartis
o Aspen
· Cancer Hormone Therapy Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Cancer Hormone Therapy Drugs Market, By Country
o U.S. Cancer Hormone Therapy Drugs Market
o Canada Cancer Hormone Therapy Drugs Market
o Mexico Cancer Hormone Therapy Drugs Market
o Europe
§ Europe Cancer Hormone Therapy Drugs Market, By Country
o UK Cancer Hormone Therapy Drugs Market
o Germany Cancer Hormone Therapy Drugs Market
o France Cancer Hormone Therapy Drugs Market
o Russia Cancer Hormone Therapy Drugs Market
o Italy Cancer Hormone Therapy Drugs Market
o Rest of Europe Cancer Hormone Therapy Drugs Market
o Asia-Pacific
§ Asia-Pacific Cancer Hormone Therapy Drugs Market, By Country
o China Cancer Hormone Therapy Drugs Market
o Japan Cancer Hormone Therapy Drugs Market
o South Korea Cancer Hormone Therapy Drugs Market
o India Cancer Hormone Therapy Drugs Market
o Southeast Asia Cancer Hormone Therapy Drugs Market
o Rest of Asia-Pacific Cancer Hormone Therapy Drugs Market
o South America
§ South America Cancer Hormone Therapy Drugs Market
o Brazil Cancer Hormone Therapy Drugs Market
o Argentina Cancer Hormone Therapy Drugs Market
o Columbia Cancer Hormone Therapy Drugs Market
o Rest of South America Cancer Hormone Therapy Drugs Market
o Middle East and Africa
§ Middle East and Africa Cancer Hormone Therapy Drugs Market
o Saudi Arabia Cancer Hormone Therapy Drugs Market
o UAE Cancer Hormone Therapy Drugs Market
o Egypt Cancer Hormone Therapy Drugs Market
o Nigeria Cancer Hormone Therapy Drugs Market
o South Africa Cancer Hormone Therapy Drugs Market
o TurkeyCancer Hormone Therapy Drugs Market
o Rest of MEA Cancer Hormone Therapy Drugs Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Cancer Hormone Therapy Drugs Market, By Type
5.1. Introduction
5.2. Global Cancer Hormone Therapy Drugs Revenue and Market Share by Type (2017-2021)
5.2.1. Global Cancer Hormone Therapy Drugs Revenue and Revenue Share by Type (2017-2021)
5.3. Tamoxifen
5.3.1. Global Tamoxifen Revenue and Growth Rate (2017-2021)
5.4. Aromatase Inhibitors
5.4.1. Global Aromatase Inhibitors Revenue and Growth Rate (2017-2021)
5.5. Antiandrogens
5.5.1. Global Antiandrogens Revenue and Growth Rate (2017-2021)
5.6. Androgen Synthesis Inhibitors
5.6.1. Global Androgen Synthesis Inhibitors Revenue and Growth Rate (2017-2021)
5.7. Other
5.7.1. Global Other Revenue and Growth Rate (2017-2021)
6. Cancer Hormone Therapy Drugs Market, By Applications
6.1. Introduction
6.2. Global Cancer Hormone Therapy Drugs Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Cancer Hormone Therapy Drugs Revenue and Revenue Share by Applications (2017-2021)
6.3. Breast Cancer
6.3.1. Global Breast Cancer Revenue and Growth Rate (2017-2021)
6.4. Prostate Cancer
6.4.1. Global Prostate Cancer Revenue and Growth Rate (2017-2021)
6.5. Other type of Cancers
6.5.1. Global Other type of Cancers Revenue and Growth Rate (2017-2021)
7. Cancer Hormone Therapy Drugs Market, By Region
7.1. Introduction
7.2. Global Cancer Hormone Therapy Drugs Revenue and Market Share by Regions
7.2.1. Global Cancer Hormone Therapy Drugs Revenue by Regions (2017-2021)
7.3. North America Cancer Hormone Therapy Drugs by Countries
7.3.1. North America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2021)
7.3.2. North America Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Cancer Hormone Therapy Drugs by Countries
7.4.1. Europe Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2021)
7.4.2. Europe Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Cancer Hormone Therapy Drugs by Countries
7.5.1. Asia-Pacific Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Cancer Hormone Therapy Drugs by Countries
7.6.1. South America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2021)
7.6.2. South America Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Cancer Hormone Therapy Drugs by Countries
7.7.1. Middle East and Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Roche
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Amgen
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Pfizer
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Teva
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Takeda
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Samyang Biopharmaceuticals
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Tolmar
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. AstraZeneca
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Novartis
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Aspen
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.1. Global Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Cancer Hormone Therapy Drugs Market Forecast by Regions (2022-2027)
9.2.1. North America Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.1.1. United States Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.1.2. Canada Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.1.3. Mexico Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.2. Europe Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.2.1. Germany Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.2.2. France Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.2.3. UK Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.2.4. Russia Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.2.5. Italy Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.3. Asia-Pacific Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.3.1. China Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.3.2. Japan Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.3.3. Korea Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.3.4. India Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.4. South America Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.4.1. Brazil Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.4.2. Argentina Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.4.3. Columbia Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.4.4. Rest of South America Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5. Middle East and Africa Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5.3. Egypt Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5.4. Nigeria Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5.5. South Africa Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5.6. Turkey Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Cancer Hormone Therapy Drugs Market Forecast (2022-2027)
9.3. Cancer Hormone Therapy Drugs Market Forecast by Type (2022-2027)
9.3.1. Cancer Hormone Therapy Drugs Forecast by Type (2022-2027)
9.3.2. Cancer Hormone Therapy Drugs Market Share Forecast by Type (2022-2027)
9.4. Cancer Hormone Therapy Drugs Market Forecast by Applications (2022-2027)
9.4.1. Cancer Hormone Therapy Drugs Forecast by Applications (2022-2027)
9.4.2. Cancer Hormone Therapy Drugs Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Cancer Hormone Therapy Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Cancer Hormone Therapy Drugs Revenue and Revenue Share by Type (2017-2019)
Figure Global Tamoxifen Revenue and Growth Rate (2017-2019)
Figure Global Aromatase Inhibitors Revenue and Growth Rate (2017-2019)
Figure Global Antiandrogens Revenue and Growth Rate (2017-2019)
Figure Global Androgen Synthesis Inhibitors Revenue and Growth Rate (2017-2019)
Figure Global Other Revenue and Growth Rate (2017-2019)
Table Global Cancer Hormone Therapy Drugs Revenue and Revenue Share by Applications (2017-2019)
Figure Global Breast Cancer Revenue and Growth Rate (2017-2019)
Figure Global Prostate Cancer Revenue and Growth Rate (2017-2019)
Figure Global Other type of Cancers Revenue and Growth Rate (2017-2019)
Table Global Cancer Hormone Therapy Drugs Revenue by Regions (2017-2019)
Figure North America Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure North America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2019)
Figure North America Cancer Hormone Therapy Drugs by Countries (2017-2019)
Figure North America Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2019)
Figure United States Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure United States Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Canada Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Mexico Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Europe Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2019)
Figure Europe Cancer Hormone Therapy Drugs by Countries (2017-2019)
Figure Europe Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Germany Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Germany Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure France Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure UK Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Russia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Italy Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Rest of Europe Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Cancer Hormone Therapy Drugs by Countries (2017-2019)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2019)
Figure China Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure China Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Japan Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Korea Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure India Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Southeast Asia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure South America Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2019)
Figure South America Cancer Hormone Therapy Drugs by Countries (2017-2019)
Figure South America Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Brazil Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Argentina Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Columbia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Rest of South America Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Cancer Hormone Therapy Drugs by Countries (2017-2019)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Saudi Arabia Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure United Arab Emirates Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Egypt Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Nigeria Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure South Africa Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Turkey Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cancer Hormone Therapy Drugs Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Table Roche Cancer Hormone Therapy Drugs Financial Overview
Table Amgen Cancer Hormone Therapy Drugs Financial Overview
Table Pfizer Cancer Hormone Therapy Drugs Financial Overview
Table Teva Cancer Hormone Therapy Drugs Financial Overview
Table Takeda Cancer Hormone Therapy Drugs Financial Overview
Table Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Financial Overview
Table Tolmar Cancer Hormone Therapy Drugs Financial Overview
Table AstraZeneca Cancer Hormone Therapy Drugs Financial Overview
Table Novartis Cancer Hormone Therapy Drugs Financial Overview
Table Aspen Cancer Hormone Therapy Drugs Financial Overview
Figure Global Cancer Hormone Therapy Drugs Revenue (Millions USD) and Growth Rate (2019-2027)
Table Cancer Hormone Therapy Drugs Market Forecast by Regions (2019-2027)
Figure North America Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure United States Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Canada Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Mexico Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Europe Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Germany Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure France Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure UK Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Russia Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Italy Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Rest of Europe Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Asia-Pacific Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure China Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Japan Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Korea Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure India Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Southeast Asia Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure South America Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Brazil Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Argentina Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Columbia Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Rest of South America Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Middle East and Africa Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Saudi Arabia Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure United Arab Emirates Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Egypt Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Nigeria Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure South Africa Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Turkey Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Cancer Hormone Therapy Drugs Market Forecast (2019-2027)
Figure Global Cancer Hormone Therapy Drugs Forecast by Type (2019-2027)
Figure Global Cancer Hormone Therapy Drugs Market Share Forecast by Type (2019-2027)
Figure Global Cancer Hormone Therapy Drugs Forecast by Type (2019-2027)
Figure Global Cancer Hormone Therapy Drugs Forecast by Applications (2019-2027)
Figure Global Cancer Hormone Therapy Drugs Market Share Forecast by Applications (2019-2027)
Figure Global Cancer Hormone Therapy Drugs Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|